The guides.

The plain-English explainers that define every term used elsewhere on the site.

• Basics Peptides 101: What They Are and How to Think About Them A plain-language orientation to what peptides actually are, which ones are proven drugs, where the gray market begins, and how to weigh the evidence.
• Reference Peptide Classes, Explained A plain-English map of the major peptide categories — GLP-1 agonists, GH secretagogues, healing peptides, melanocortins, nootropics and more — with examples and what each is claimed to do.
• Reference A Plain-English Peptide Glossary Plain-English definitions of common peptide terms, from agonist to subcutaneous, with honest safety and legal context.
• Science How Peptides Are Made: Synthesis, Purity, and Why Quality Varies How synthetic peptides are actually manufactured, where impurities come from, how purity is measured, and why gray-market quality is so inconsistent.
• Science Peptide Half-Life and Pharmacokinetics, in Plain Terms What half-life really means, why native peptides clear in minutes, and how chemical modifications stretch that to days. Educational only -- no dosing.

How to evaluate a study, a label, or a certificate of analysis without taking the marketing copy at face value.

• Evidence How to Read a Peptide Study Without Getting Fooled A plain-English checklist for judging peptide research — study design, endpoints, funding, and preprints — tied to our evidence grades.
• Testing How to Read a Certificate of Analysis (COA) A plain-English guide to reading a peptide Certificate of Analysis: HPLC purity, mass-spec identity, safety tests, and spotting fakes.

What the rules actually say — about ownership, about anti-doping, about that "research use only" sticker.

• Regulation Are Peptides Legal? The U.S. Status in 2026 Peptide legality depends on the molecule, its intended use, and who is selling it. A plain look at FDA, DEA, and anti-doping rules in 2026.
• Legal What "Research Use Only" Actually Means Why "research use only" and "not for human consumption" are regulatory and marketing labels — not a safety claim, and not a loophole.
• Safety The Gray Market: Sourcing, Purity, and Contamination How the research-peptide gray market works and why purity, identity, and sterility vary batch to batch — a harm-reduction reference.
• Legal Peptides and Anti-Doping: WADA Status Explained How WADA classifies peptides (S0, S2, S4), what "prohibited at all times" means, TUEs, and why many popular peptides are banned in tested sport.

What to expect, what to watch for, and when to stop.

• Safety Peptide Side Effects and Safety: General Principles Why peptide safety can't be generalized, the side effects that actually show up, and the extra risks of unapproved gray-market material. Not medical advice.
• Safety How to Spot a Scam Peptide Vendor Consumer red flags for spotting scam peptide vendors: fake COAs, no batch testing, miracle claims, fake reviews, and sketchy payment.
• Testing How to Vet a Peptide Source A practical process for judging any peptide seller: demand a batch-matched independent COA, verify it yourself, and understand what testing can and cannot tell you. Names no vendors.

The mechanical stuff — reconstitution, storage, sterility, and routes.

• Handling How to Reconstitute a Peptide (and Handle It Safely) A plain-English, harm-reduction guide to reconstituting lyophilized peptides: bacteriostatic water, sterile technique, the concentration math, and storage. Not dosing advice.
• Handling Bacteriostatic Water, Sterility, and Aseptic Technique What bacteriostatic water actually is, why a preservative is not the same as sterility, and the aseptic basics that prevent the most common avoidable harms.
• Handling Peptide Storage and Stability How peptides degrade, why lyophilized vials outlast reconstituted ones, and the storage and beyond-use principles that limit real-world stability.
• Reference Routes of Administration, Explained A conceptual, evidence-based overview of how peptides are delivered—injection, oral, intranasal, topical—and what bioavailability means.

Whole-class primers for the compounds that need them.

• Science GLP-1 and Incretin Drugs, Explained A plain-language guide to the incretin hormone system, the GLP-1 drug generations, what the trials show, the known risks, and the 2025-2026 regulatory landscape.